Skip to content

Clinical trials

Recruiting Phase 1 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 1 Status: Recruiting Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20221
20231
20246
202515
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital3
China Immunotech (Beijing) Biotechnology Co., Ltd.3
The Children's Hospital of Zhejiang University School of Medicine3
Chongqing Precision Biotech Co., Ltd2
Nanjing Bioheng Biotech Co., Ltd.2
Allogene Therapeutics1
AstraZeneca1
CRISPR Therapeutics1
Changhai Hospital1
CytoCares Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic33
Lupus Erythematosus, Systemic22
Myositis16
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis14
Autoimmune Diseases13
Sjogren's Syndrome9
Arthritis, Rheumatoid8
Lupus Nephritis6
Scleroderma, Diffuse6
Antiphospholipid Syndrome5

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.